Numbers from a Trial That Has Not Yet Been Peer Reviewed
An experimental once daily inhaled drug sharply reduced resistance in the lung's blood vessels in a midstage trial of people with one of the harder forms of pulmonary hypertension to treat. Results were presented Sept. 8 at the European Respiratory Society International Congress in Basel, in a study of 135 adults.